CMO Formex and CRO BioDuro merge operations

San Diego-based contract manufacturer Formex has merged with China-based BioDuro. The merged groups will operate under the BioDuro name out of San Diego. Terms of the deal were not disclosed. BioDuro said in a statement that the combined group will have access to BioDuro's 100,000-square-foot facility in Beijing, where it focuses on biosimilars and other products, and a 44,000-square-foot Formex facility in San Diego. Release

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

After months of delay for ultra-pricey gene therapy Zynteglo, Bluebird Bio is hoping to dose its first German patients in the first half of the year.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)